Associate Director, Benefit-Risk Epidemiology
Janssen Pharmaceuticals
Laura Bozzi, MS, PhD, is Associate Director of Benefit-Risk Assessment in the Global Epidemiology Organization at Janssen Pharmaceuticals of Johnson & Johnson in New Jersey. Laura leads clinical teams and safety teams in patient preference studies and benefit-risk (B-R) assessments for safety decisions, regulatory submissions and health authority advisory committee meetings. She also has leadership roles as an in-house expert in B-R assessment and in external policy and methodology on B-R and patient preference studies. Laura has been a key member of Epidemiology and the Benefit-Risk Team since joining Janssen in July 2021. Prior to Janssen, Laura completed her MS in Epidemiology and PhD in Pharmaceutical Health Services Research from the University of Maryland, Baltimore.
